What percentage of your patients with culture-proven MAC lung disease are treated? And why do you withhold treatment in some cases?

What percentage of your patients with culture-proven MAC lung disease are treated? And why do you withhold treatment in some cases?

What percentage of your patients with culture-proven MAC lung disease are treated? And why do you withhold treatment in some cases?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Patrick Flume, MD

Patrick Flume, MD

Professor of Medicine and Pediatrics
Medical University of South Carolina
Powers-Huggins Endowed Chair for Cystic Fibrosis
University of South Carolina
Charleston, South Carolina